Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
Ontology highlight
ABSTRACT: A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic1-8. For global deployment and pandemic control, a vaccine that requires only a single immunization would be optimal. Here we show the immunogenicity and protective efficacy of a single dose of adenovirus serotype 26 (Ad26) vector-based vaccines expressing the SARS-CoV-2 spike (S) protein in non-human primates. Fifty-two rhesus macaques (Macaca mulatta) were immunized with Ad26 vectors that encoded S variants or sham control, and then challenged with SARS-CoV-2 by the intranasal and intratracheal routes9,10. The optimal Ad26 vaccine induced robust neutralizing antibody responses and provided complete or ne
SUBMITTER: Mercado NB
PROVIDER: S-EPMC7581548 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA